• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者对管理干眼疾病的药物偏好:药物副作用的重要性。

Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects.

机构信息

Signature Programme in Health Services and Systems Research, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.

Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.

出版信息

Patient. 2022 Nov;15(6):679-690. doi: 10.1007/s40271-022-00586-8. Epub 2022 Jun 14.

DOI:10.1007/s40271-022-00586-8
PMID:35697974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9192251/
Abstract

OBJECTIVES

The side effects of dry eye medications can lead to medication non-adherence and, eventually, to poor outcomes. This study aimed to quantify to what extent the side effects of dry eye disease (DED) medications (burning/stinging sensation and blurring) are important to patients compared to medication benefits or costs.

METHODS

Patients diagnosed with DED were recruited at a referral eye center in Singapore (n = 139). This study utilized a Discrete Choice Experiment where patients were presented with 10 choice tasks where they were asked to choose between their current medication (or no medication), and two hypothetical medications that varied based on five attributes: duration of burning/stinging, duration of blurring, time to medication effectiveness, medication frequency, and out-of-pocket cost. The main outcomes were relative attribute importance and predicted uptake.

RESULTS

Latent class logistic regressions found two groups with distinct preferences. For both classes, duration of burning/stinging (Class 1 = 23%, Class 2 = 29%) and cost (Class 1 = 24%, Class 2 = 27%) were the most important attributes while duration of blurring (Class 1 = 15%, Class 2 = 9%) was the least important. The predicted uptake of a medication increased 18 percentage-points when burning/stinging duration decreased from 2 h to a few minutes. The predicted uptake for new medications was lowest for those on medication with well-controlled symptoms and highest for those who were not on medication and could not control their symptoms effectively.

CONCLUSION

This study showed that duration of burning/stinging was an important factor when choosing medications. Incorporating patient preferences in medication decisions can potentially improve patient acceptance of a treatment regimen.

摘要

目的

干眼症药物的副作用可能导致患者不遵医嘱,最终导致治疗效果不佳。本研究旨在定量评估干眼症(DED)药物(烧灼感/刺痛感和模糊感)的副作用相对于药物益处或成本对患者的重要程度。

方法

在新加坡的一家眼科转诊中心招募了被诊断为 DED 的患者(n=139)。本研究采用离散选择实验,患者需在 10 项选择任务中进行选择,其中包括他们目前的药物(或无药物)和两种基于五个属性的假设药物:烧灼感/刺痛感持续时间、模糊感持续时间、药物起效时间、用药频率和自付费用。主要结局为相对属性重要性和预测采用率。

结果

潜在类别逻辑回归发现两组患者的偏好存在明显差异。对于两组患者,烧灼感/刺痛感持续时间(第 1 类=23%,第 2 类=29%)和成本(第 1 类=24%,第 2 类=27%)是最重要的属性,而模糊感持续时间(第 1 类=15%,第 2 类=9%)是最不重要的属性。当烧灼感/刺痛感持续时间从 2 小时减少到几分钟时,预测采用率增加了 18 个百分点。对于症状得到良好控制的用药患者,新药物的预测采用率最低;对于那些正在用药但无法有效控制症状的患者,预测采用率最高。

结论

本研究表明,烧灼感/刺痛感持续时间是选择药物时的一个重要因素。在药物决策中纳入患者的偏好,可能会提高患者对治疗方案的接受程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2718/9192251/60d30ecdb3ef/40271_2022_586_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2718/9192251/785943242643/40271_2022_586_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2718/9192251/798e25d18188/40271_2022_586_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2718/9192251/60d30ecdb3ef/40271_2022_586_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2718/9192251/785943242643/40271_2022_586_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2718/9192251/798e25d18188/40271_2022_586_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2718/9192251/60d30ecdb3ef/40271_2022_586_Fig3_HTML.jpg

相似文献

1
Patient Medication Preferences for Managing Dry Eye Disease: The Importance of Medication Side Effects.患者对管理干眼疾病的药物偏好:药物副作用的重要性。
Patient. 2022 Nov;15(6):679-690. doi: 10.1007/s40271-022-00586-8. Epub 2022 Jun 14.
2
Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment.患者对治疗 2 型糖尿病药物的偏好:一项离散选择实验。
Value Health. 2020 Jul;23(7):842-850. doi: 10.1016/j.jval.2020.01.023. Epub 2020 Jun 21.
3
Older adult patient preferences for the content and format of prescription medication labels - A best-worst scaling and discrete choice experiment study.老年患者对处方药标签内容和格式的偏好 - 最佳最差标度和离散选择实验研究。
Res Social Adm Pharm. 2023 Nov;19(11):1455-1464. doi: 10.1016/j.sapharm.2023.07.009. Epub 2023 Jul 20.
4
Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists.患者偏好和经济因素在治疗决策中起着重要作用:风湿病学家的离散选择实验
Rheumatology (Oxford). 2017 Jan;56(1):68-76. doi: 10.1093/rheumatology/kew328. Epub 2016 Oct 22.
5
Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.患者对抗骨质疏松药物治疗的偏好:一项跨欧洲的离散选择实验
Rheumatology (Oxford). 2017 Jul 1;56(7):1167-1176. doi: 10.1093/rheumatology/kex071.
6
Patients' Preferences for Artificial Intelligence Applications Versus Clinicians in Disease Diagnosis During the SARS-CoV-2 Pandemic in China: Discrete Choice Experiment.中国 SARS-CoV-2 大流行期间,患者对人工智能应用与临床医生在疾病诊断中的偏好:离散选择实验。
J Med Internet Res. 2021 Feb 23;23(2):e22841. doi: 10.2196/22841.
7
Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia.理解合理的药物不依从性。澳大利亚社区样本中的离散选择实验。
BMC Fam Pract. 2012 Jun 20;13:61. doi: 10.1186/1471-2296-13-61.
8
Chinese patients' preference for pharmaceutical treatments of osteoporosis: a discrete choice experiment.中国患者对骨质疏松症药物治疗的偏好:一项离散选择实验。
Arch Osteoporos. 2019 Jul 31;14(1):85. doi: 10.1007/s11657-019-0624-z.
9
Assessment of Dry Eye Symptoms: Current Trends and Issues of Dry Eye Questionnaires in Japan.干眼症状评估:日本干眼问卷的现状及问题。
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES23-DES28. doi: 10.1167/iovs.18-24570.
10
Topical cyclosporine A therapy for dry eye syndrome.局部用环孢素A治疗干眼症综合征。
Cochrane Database Syst Rev. 2019 Sep 13;9(9):CD010051. doi: 10.1002/14651858.CD010051.pub2.

引用本文的文献

1
Dry Eye Disease: From Causes to Patient Care and Clinical Collaboration-A Narrative Review.干眼症:从病因到患者护理及临床协作——一篇叙述性综述
Ophthalmol Ther. 2025 May 28. doi: 10.1007/s40123-025-01161-8.
2
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.
3
Applications of Diquafosol Sodium in Ophthalmology: A Comprehensive Review of Therapeutic Utility.地夸磷索钠在眼科的应用:治疗效用的全面综述

本文引用的文献

1
Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment.患者对治疗 2 型糖尿病药物的偏好:一项离散选择实验。
Value Health. 2020 Jul;23(7):842-850. doi: 10.1016/j.jval.2020.01.023. Epub 2020 Jun 21.
2
Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease.使用抗炎局部用药治疗干眼病患者的治疗满意度
Clin Ophthalmol. 2020 Mar 19;14:875-883. doi: 10.2147/OPTH.S233194. eCollection 2020.
3
Comparing the needs and preferences of patients with moderate and severe dry eye symptoms across four countries.
Life (Basel). 2025 Mar 17;15(3):484. doi: 10.3390/life15030484.
4
How Much Better is Faster? Empirical Tests of QALY Assumptions in Health-Outcome Sequences.速度快多少会更好?健康结果序列中QALY假设的实证检验。
Pharmacoeconomics. 2025 Jan;43(1):45-52. doi: 10.1007/s40273-024-01437-0. Epub 2024 Oct 4.
5
An Overview of Data Collection in Health Preference Research.健康偏好研究中的数据收集概述
Patient. 2024 Apr 25. doi: 10.1007/s40271-024-00695-6.
6
The Efficacy and Safety of Rebamipide Ophthalmic Suspension (OPC-12759) in Patients with Dry Eye Disease: A Systematic Review of Randomized Controlled Trials.瑞巴派特眼用混悬液(OPC-12759)治疗干眼病患者的疗效和安全性:随机对照试验的系统评价
J Clin Med. 2023 Nov 17;12(22):7155. doi: 10.3390/jcm12227155.
比较四个国家中患有中度和重度干眼症状患者的需求和偏好。
BMJ Open Ophthalmol. 2019 Dec 15;4(1):e000360. doi: 10.1136/bmjophth-2019-000360. eCollection 2019.
4
Exploring variables associated with medication non-adherence in patients with COPD.探讨 COPD 患者药物不依从相关的变量。
Int J Clin Pharm. 2019 Oct;41(5):1202-1209. doi: 10.1007/s11096-019-00895-3. Epub 2019 Aug 30.
5
Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren's Syndrome Dry Eye.新型 0.05%环孢素 A 眼用纳米乳治疗原发性干燥综合征干眼的疗效和安全性评价。
Ocul Immunol Inflamm. 2020 Apr 2;28(3):370-378. doi: 10.1080/09273948.2019.1587470. Epub 2019 Apr 15.
6
A Guide to Measuring and Interpreting Attribute Importance.属性重要性的测量和解释指南。
Patient. 2019 Jun;12(3):287-295. doi: 10.1007/s40271-019-00360-3.
7
Disruption in time projection and non-adherence to long-term therapies.时间预测的中断以及对长期治疗的不依从。
Patient Prefer Adherence. 2018 Nov 9;12:2363-2375. doi: 10.2147/PPA.S180280. eCollection 2018.
8
TFOS DEWS II Epidemiology Report.TFOS DEWS II 流行病学报告。
Ocul Surf. 2017 Jul;15(3):334-365. doi: 10.1016/j.jtos.2017.05.003. Epub 2017 Jul 20.
9
TFOS DEWS II Definition and Classification Report.TFOS DEWS II 定义与分类报告。
Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
10
Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older.美国18岁及以上成年人中确诊的干眼病患病率。
Am J Ophthalmol. 2017 Oct;182:90-98. doi: 10.1016/j.ajo.2017.06.033. Epub 2017 Jul 10.